About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us
 

Welcome to DAXOR Corporation!

 
 

6/13/2013 - Daxor Corporation Announces the Bi-Monthly Publication of a Medical Column by Its President, Dr. Joseph Feldschuh

  

5/16/2013 - Daxor Corporation Announces Placement of BVA-100 Blood Volume Analyzer at Austin Nuclear Pharmacy, Inc.

  

3/21/2013 - Heartbeat Clinic in Dallas Acquires Blood Volume Analyzer & Daxor Corporation Announces 250,000 Share Buyback

  
 

______________________

 
     
  Form N-Q for Mar 31, 2013  
  Form N-CSR for Dec 31, 2012  
  Form N-2  
  2011 Form 10-K  
  2011 Annual Report  
 

DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility.


The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.

 

Find out more about the BVA-100 >

 

See where blood volume tests are being performed >

 

Watch San Antonio's KENS5 station feature on the BVA-100
(MPEG video; 19 MB) >


 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806


© 2013 DAXOR Corporation. All Rights Reserved.